|Packaging Size||Dispo pack|
|Brand||Myterm - H 250|
|Treatment||Hydroxyprogesterone caproate injection is a man-made progestin hormone. It is used in pregnant women|
|Also Gives||PCD Pharma Franchise, Third Party Manufacturing|
|Shelf Life||2 years|
Brand Name :- Myterm- H 250
Composition :- Hydroxyprogesterone Caproate
Packing : Dispo pack 1 ml
Mrp : 89.00
Reduces the risk of spontaneous Recurrent pre-term birth.
MEDICATION USED FOR
Myterm -H 250 ( Hydroxyprogesterone Caproate ) is a potent ,long-acting ,progestational steriod ester .Myterm-H 250 helps reducing the risk of preterm birth in women with a singleton Pregnancy who have a history of singleton spontaneous preterm birth . Myterm -H 250 transforms prolifeative endothelium into secretory endothelium , induces mammary gland duct development .
Weekly injections of 17-alpha-hydroxyprogesterone caporate begining of 16-20 weeks gestation resulted in a substanital reduction in the rate of spontaneous recurrent preterm birth. Long term follow -up of children exposed in -utero to the drug has normal growth and development and normal scores for gender specific roles . In Conclusion , 17 alpha-hydroxyprogesterone caproate is currently the only drug with sufficient evidence to support its use for prevention of spontaneous recurrent preterm birth.
In Pregnant women
In Non -Pregnant Women
For the treatment of advanced adenocarcinoma of the uterine corpus
In the management of amenorrhea ( primary and secondary )
In the management of abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology ,such as submucous fibroids or uterine cancer .